Primary hyperoxaluria is an inherited disorder that results from the overproduction of endogenous oxalate, leading to recurrent kidney stones, nephrocalcinosis, kidney failure and life-threatening systemic disease. This Consensus Statement from ERKNet and OxalEurope provides recommendations for the management of primary hyperoxaluria, including consideration of conventional therapies, new therapies and recommendations for patient follow-up.
Understanding medical guidelines can be challenging, which is why we have summarized this important document in layman’s language. Our goal is to ensure you have access to the information you need to make informed decisions about your health or the health of your child.
These guidelines aim to help healthcare providers manage PH more effectively and ensure that patients receive the best possible care based on the latest research and expert consensus. If you have any specific concerns or questions about managing PH, it's important to discuss them with your healthcare provider.
Primary Hyperoxaluria (PH) - Overview | What is PH? Primary hyperoxaluria (PH) is an inherited, genetic condition in which the body produces too much oxalate. The cause of the oxalate overproduction is a defect of an specific enzyme, most often located in the liver. Oxalate is a substance that is useless for the body and normally leaves the body through urine, but in high amounts, it can form kidney stones and cause kidney damage. Types of PH: There are three types of PH (PH1, PH2, and PH3), with PH1 being the most common and severe. | |||
Diagnosis and Testing | Importance of Genetic Testing: Genetic testing is crucial for diagnosing PH. It helps determine the specific type of PH, which is important for treatment and management. Symptoms and Signs: Common signs include recurrent kidney stones, kidney damage (kidney tissue calcification = nephrocalcinosis seen on ultrasound), and eventually kidney failure. In case of severe kidney dysfunction, oxalate will be stored throughout the body and this may cause disease of bones, eye, nerves, vessels and the heart. This condition is called systemic oxalosis. | |||
Treatment Recommendations | Conservative Therapy:
Advanced Therapies:
Dialysis and Transplantation:
| |||
Monitoring and Follow-Up | Regular Check-Ups:
| |||
Special Considerations for Low-Resource Settings | Adapted Guidelines: Recommendations are provided for managing PH in areas with limited medical resources, emphasizing the most critical aspects of care that can be adapted to diJerent settings. | |||
Research and Future Directions | Ongoing Research:
|
Grootho&, J.W., Metry, E., Deesker, L. et al. Nat Rev Nephrol (2023). doi: 10.1038/s41581-02200661-1